Skip to content
DataLookout
Menu

BioBoneNCT06658379

Prospective Validation Study of the CD8+TEMRA Cells As a Prognostic Biomarker of Healing Outcome After Fracture

StatusUnknown
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
  2. Study First Submitted
  • Minor: routine updates

Endpoints

Primary

Clinical assessement of the fracture consolidation at first study endpoint based on radiological images
Timeframe: From surgery to 19 weeks post surgery

Secondary (1)

clinical assessement of the fracture consolidation at second study endpoint based on radiological images

Arms and interventions

fracture cohort

Humerus fracture, forearm fracture, femoral fracture. tibia fracture

Diagnostic tests: CD8+TEMRA

Sites

7 sites in 1 country